ESA Treatment Selection in MDS

Clinical insights on selecting appropriate erythropoiesis-stimulating agents in patients with myelodysplastic syndromes.

Related Keywords

,Evolving Treatment Landscape ,Myelodysplastic Syndromes ,Mds ,Mds Treatment ,Myelodysplastic Syndromes Treatment ,Erythropoiesis ,Esa ,Darbepoetin ,Erythropoiesis Stimulating Agent ,